Synthesis and characterization of new Piperazine-Dithiocarbamate compounds as potent MAO-A inhibitors

Abstract

Monoamine oxidase (MAO) enzymes have an important place in neurodegenerative diseases. While MAO-A inhibitors are used in depression; MAO-B enzyme has an important place in Parkinson's disease. Within the scope of this study, 7 new piperazine-dithiocarbamate derivative compounds were synthesized. Structure determinations of the compounds were performed using 1H-NMR, ¹³C-NMR and HRMS spectroscopic methods. The MAO inhibitory activities of the compounds were determined by in vitro fluorometric methods. According to the obtained results, compound 2d with IC₅₀=0.108±0.004 µM; compound 2e exhibited inhibitory activity with an IC₅₀=0.074±0.003 µM.

Keywords

• Dithiocarbamate
• HRMS
• Monoamine oxidase
• NMR
• Piperazine

References

1. 1. Mattsson C, Svensson P, Sonesson C. A novel series of 6-substituted 3-(pyrrolidin-1-ylmethyl) chromen-2-ones as selective monoamine oxidase (MAO) A inhibitors. Eur. J. Med. Chem. (2014);73:177-86 https://doi.org/10.1016/j.ejmech.2013.11.035
2. 2. Choi JW, Jang BK, Cho NC, Park JH, Yeon SK, Ju EJ, Lee YS, Han G, Pae AN, Kim DJ, Park KD. Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors. Bioorg. Med. Chem. (2015);23(19):6486-96 https://doi.org/10.1016/j.bmc.2015.08.012
3. 3. He X, Chen YY, Shi JB, Tang WJ, Pan ZX, Dong ZQ, Song BA, Li J, Liu XH. New coumarin derivatives: Design, synthesis and use as inhibitors of hMAO. Bioorg. Med. Chem. (2014);22(14):3732-8 https://doi.org/10.1016/j.bmc.2014.05.002
4. 4. Baek SC, Lee HW, Ryu HW, Kang MG, Park D, Kim SH, Cho ML, Oh SR, Kim H. Selective inhibition of monoamine oxidase A by hispidol. Bioorg. Med. Chem. Lett. (2018);28(4):584-8 https://doi.org/10.1016/j.bmcl.2018.01.049
5. 5. Baek SC, Kang MG, Park JE, Lee JP, Lee H, Ryu HW, Park CM, Cho ML, Oh SR, Kim H. Osthenol, a prenylated coumarin, as a monoamine oxidase A inhibitor with high selectivity. Bioorg. Med. Chem. Lett. (2019);29(6):839-43 https://doi.org/10.1016/j.bmcl.2019.01.016
6. 6. Mostert S, Petzer A, Petzer JP. The evaluation of 1, 4-benzoquinones as inhibitors of human monoamine oxidase. Eur. J. Med. Chem. (2017);135:196-203 https://doi.org/10.1016/j.ejmech.2017.04.055
7. 7. Distinto S, Meleddu R, Yanez M, Cirilli R, Bianco G, Sanna ML, Sanna ML, Arridu A, Cossu P, Cottiglia F, . Drug design, synthesis, in vitro and in silico evaluation of selective monoaminoxidase B inhibitors based on 3-acetyl-2-dichlorophenyl-5-aryl-2, 3-dihydro-1, 3, 4-oxadiazole chemical scaffold. Eur. J. Med. Chem. (2016);108:542-52 https://doi.org/10.1016/j.ejmech.2015.12.026
8. 8. Tong X, Chen R, Zhang TT, Han Y, Tang W-J, Liu XH. Design and synthesis of novel 2-pyrazoline-1-ethanone derivatives as selective MAO inhibitors. Bioorg. Med. Chem. (2015);23(3):515-25 https://doi.org/10.1016/j.bmc.2014.12.010

9. 9. Suthar SK, Bansal S, Alam MM, Jaiswal V, Tiwari A, Chaudhary A, Alex AT, Joseph A. Design, synthesis, and biological evaluation of oxindole derivatives as antidepressive agents. Bioorg. Med. Chem. Lett. (2015);25(22):5281-5 https://doi.org/10.1016/j.bmcl.2015.09.048
10. 10. Manzoor S, Hoda N. A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer’s disease agents: A review. Eur. J. Med. Chem. (2020);206:112787 https://doi.org/10.1016/j.ejmech.2020.112787
11. 11. Khattab SN, Moneim SAA, Bekhit AA, El Massry AM, Hassan SY, El-Faham A, Ahmed HEA, Amer A. Exploring new selective 3-benzylquinoxaline-based MAO-A inhibitors: design, synthesis, biological evaluation and docking studies. Eur. J. Med. Chem. (2015);93:308-20 https://doi.org/10.1016/j.ejmech.2015.02.020
12. 12. Hussein FM, Abdulsada SH, Khamis WM, Abdulredda S, Abbas BF. Effect of Ferric Nanoparticles on Monoaminoxidase and Acetylcholinesterase in Healthy Human Sera. Asian J. Chem. (2018);30(8):1747-50.
13. 13. Chirkova ZV, Kabanova MV, Filimonov SI, Abramov IG, Petzer A, Petzer JP, Firgang SI, Suponitsky KY. Inhibition of monoamine oxidase by indole-5, 6-dicarbonitrile derivatives. Bioorg. Med. Chem. Lett. (2015);25(6):1206-11 https://doi.org/10.1016/j.bmcl.2015.01.061
14. 14. Lewellyn K, Bialonska D, Chaurasiya ND, Tekwani BL, Zjawiony JK. Synthesis and evaluation of aplysinopsin analogs as inhibitors of human monoamine oxidase A and B. Bioorg. Med. Chem. Lett. (2012);22(15):4926-9 https://doi.org/10.1016/j.bmcl.2012.06.058
15. 15. Huang C, Xiong J, Guan H-D, Wang C-H, Lei X, Hu JF. Discovery, synthesis, biological evaluation and molecular docking study of (R)-5-methylmellein and its analogs as selective monoamine oxidase A inhibitors. Bioorg. Med. Chem. (2019);27(10):2027-40 https://doi.org/10.1016/j.bmc.2019.03.060
16. 16. Qhobosheane MA, Petzer A, Petzer JP, Legoabe LJ. Synthesis and evaluation of 2-substituted 4 (3H)-quinazolinone thioether derivatives as monoamine oxidase inhibitors. Bioorg. Med. Chem. (2018);26(20):5531-7 https://doi.org/10.1016/j.bmc.2018.09.032
17. 17. Nel MS, Petzer A, Petzer JP, Legoabe LJ. 2-Benzylidene-1-indanone derivatives as inhibitors of monoamine oxidase. Bioorg. Med. Chem. Lett. (2016);26(19):4599-605 https://doi.org/10.1016/j.bmcl.2016.08.067
18. 18. Evranos-Aksöz B, Yabanoğlu-Çiftçi S, Uçar G, Yelekçi K, Ertan R. Synthesis of some novel hydrazone and 2-pyrazoline derivatives: Monoamine oxidase inhibitory activities and docking studies. Bioorg. Med. Chem. Lett. (2014);24(15):3278-84 https://doi.org/10.1016/j.bmcl.2014.06.015
19. 19. Sağlık BN, Çavuşoğlu BK, Osmaniye D, Levent S, Çevik UA, Ilgın S, Özkay Y, Kaplancıklı ZA, Öztürk Y. In vitro and in silico evaluation of new thiazole compounds as monoamine oxidase inhibitors. Bioorg. Chem. (2019);85:97-108 https://doi.org/10.1016/j.bioorg.2018.12.019
20. 20. Can ÖD, Osmaniye D, Özkay ÜD, Sağlık BN, Levent S, Ilgın S, Baysal M, Özkay Y, Kaplancıklı ZA. MAO enzymes inhibitory activity of new benzimidazole derivatives including hydrazone and propargyl side chains. Eur. J. Med. Chem. (2017);131:92-106 https://doi.org/10.1016/j.ejmech.2017.03.009
21. 21. Can NÖ, Osmaniye D, Levent S, Sağlık BN, Korkut B, Atlı Ö, Özkay Y, Kaplancıklı ZA. Design, synthesis and biological assessment of new thiazolylhydrazine derivatives as selective and reversible hMAO-A inhibitors. Eur. J. Med. Chem. (2018);144:68-81 https://doi.org/10.1016/j.ejmech.2017.12.013
22. 22. Ilgın S, Osmaniye D, Levent S, Sağlık BN, Acar Çevik U, Çavuşoğlu BK, Özkay Y, Kaplancıklı ZA. Design and synthesis of new benzothiazole compounds as selective hMAO-B inhibitors. Molecules. (2017);22(12):2187 https://doi.org/10.3390/molecules22122187
23. 23. Can NÖ, Osmaniye D, Levent S, Sağlık BN, Inci B, Ilgın S, Özkay Y, Kaplancıklı ZA. Synthesis of new hydrazone derivatives for MAO enzymes inhibitory activity. Molecules. (2017);22(8):1381 https://doi.org/10.3390/molecules22081381
24. 24. Tok F, Uğraş Z, Sağlık BN, Özkay Y, Kaplancıklı ZA, Koçyiğit-Kaymakçıoğlu B. Novel 2, 5-disubstituted-1, 3, 4-oxadiazole derivatives as MAO-B inhibitors: Synthesis, biological evaluation and molecular modeling studies. Bioorg. Chem. (2021);112:104917 https://doi.org/10.1016/j.bioorg.2021.104917
25. 25. Tok F, Sağlık BN, Özkay Y, Ilgın S, Kaplancıklı ZA, Koçyiğit-Kaymakçıoğlu B. Synthesis of new hydrazone derivatives and evaluation of their monoamine oxidase inhibitory activity. Bioorg. Chem. (2021):105038 https://doi.org/10.1016/j.bioorg.2021.105038